venBio Select Advisor as of Dec. 31, 2015
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 28 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 14.3 | $40M | 1.3M | 31.60 | |
| Amicus Therapeutics (FOLD) | 12.3 | $34M | 3.5M | 9.70 | |
| Lion Biotechnologies | 8.8 | $25M | 3.2M | 7.72 | |
| La Jolla Pharmaceuticl Com Par | 7.6 | $21M | 784k | 27.00 | |
| Pernix Therapeutics Holdings | 5.5 | $15M | 5.1M | 2.95 | |
| Dermira | 4.4 | $12M | 355k | 34.61 | |
| Teligent | 4.4 | $12M | 1.4M | 8.90 | |
| Vanda Pharmaceuticals (VNDA) | 4.2 | $12M | 1.3M | 9.31 | |
| Agenus | 3.6 | $10M | 2.2M | 4.54 | |
| Sorrento Therapeutics (SRNE) | 3.6 | $10M | 1.1M | 8.71 | |
| Oncothyreon | 3.3 | $9.1M | 4.1M | 2.22 | |
| Neuroderm Ltd F | 3.2 | $8.9M | 520k | 17.05 | |
| Nantkwest | 3.2 | $8.8M | 599k | 14.73 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $7.7M | 550k | 13.95 | |
| Aegerion Pharmaceuticals | 2.7 | $7.4M | 733k | 10.10 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $7.2M | 127k | 56.57 | |
| Axovant Sciences | 2.0 | $5.5M | 307k | 18.03 | |
| Veracyte (VCYT) | 1.9 | $5.3M | 741k | 7.20 | |
| Egalet | 1.7 | $4.8M | 433k | 11.02 | |
| Innocoll | 1.5 | $4.2M | 502k | 8.30 | |
| Fortress Biotech | 1.3 | $3.7M | 1.3M | 2.79 | |
| Trillium Therapeutics, Inc. Cmn | 1.1 | $3.2M | 254k | 12.61 | |
| Vericel (VCEL) | 1.1 | $2.9M | 1.1M | 2.58 | |
| Tonix Pharmaceuticls | 0.9 | $2.6M | 340k | 7.67 | |
| Accelr8 Technology | 0.9 | $2.4M | 113k | 21.49 | |
| Alliqua | 0.7 | $1.8M | 839k | 2.14 | |
| Cellectis S A (CLLS) | 0.4 | $1.1M | 35k | 31.03 | |
| Catalyst Biosciences | 0.1 | $224k | 72k | 3.13 |
